Herbal medicines for the treatment of nonalcoholic steatohepatitis: Current scenario and future prospects

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Jadeja, Ravirajsinh ^a   Devkar, Ranjitsinh V ^b   Nammi, Srinivas ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b M S UNIVERSITY OF BARODA   (India)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALISMA ORIENTALIS EXTRACT; ANTIFIBROTIC AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIOBESITY AGENT; ANTIOXIDANT; CISSUS QUADRANGULARIS EXTRACT; CLERODENDRON GLANDULOSUM EXTRACT; CURCUMA LONGA EXTRACT; CYTOPROTECTIVE AGENT; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; ERIOBOTRYA JAPONICA EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GREEN TEA EXTRACT; INSULIN SENSITIZING AGENT; LINUM USITATISSIMUM EXTRACT; NATURAL PRODUCT; NELUMBO NUCIFERA EXTRACT; PHYLLANTHUS URINARIA EXTRACT; PICRORHIZA KURROA EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PLATYCODON GRANDIFLORUM EXTRACT; POMEGRANATE EXTRACT; SALACIA OBLONGA EXTRACT; SIDA RHOMBIFOLIA EXTRACT; SILYBUM MARIANUM EXTRACT; TEUCRIUM POLIUM EXTRACT; UNCLASSIFIED DRUG;

ALISMA; ALISMA ORIENTALIS; ANIMAL MODEL; BARIATRIC SURGERY; CALORIC INTAKE; CAMELLIA SINENSIS; CISSUS QUADRANGULARIS; CLERODENDRON GLANDULOSUM; CURCUMA LONGA; DRUG FORMULATION; ELEUTHEROCOCCUS SENTICOSUS; EXERCISE; GERMANDER; GINGER; GINKGO BILOBA; HERBAL MEDICINE; HUMAN; LIFESTYLE MODIFICATION; LINSEED; LOQUAT; NELUMBO NUCIFERA; NONALCOHOLIC FATTY LIVER; NONHUMAN; OLIVE TREE; PATHOGENESIS; PHYLLANTHUS; PHYLLANTHUS URINARIA; PICRORHIZA KURROA; PLATYCODON; POMEGRANATE; REVIEW; SALACIA; SALACIA OBLONGA; SIDA RHOMBIFOLIA; SILYBUM MARIANUM; VERBENACEAE; WEIGHT REDUCTION;

EID: 84903625011     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/648308     Document Type: Review

References (175)

1. Chalasani N., Younossi Z., Lavine J. E., Diehl A. M., Brunt E. M., Cusi K., Charlton M., Sanyal A. J., The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012 55 6 2005 2023 2-s2.0-84861543083 10.1002/hep.25762
2. Paschos P., Paletas K., Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 2009 13 1 9 19 2-s2.0-65749115425
3. Ludwig J., Viggiano T. R., McGill D. B., Ott B. J., Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings 1980 55 7 434 438 2-s2.0-0019152816 (Pubitemid 10057164)
4. Beaton M. D., Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Canadian Journal of Gastroenterology 2012 26 6 353 357 2-s2.0-84862636851
5. Durazzo M., Belci P., Collo A., Grisoglio E., Bo S., Focus on therapeutic strategies of nonalcoholic fatty liver disease. International Journal of Hepatology 2012 2012 9 464706 10.1155/2012/464706
6. Lam B., Younossi Z. M., Review: treatment options for nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 2010 3 2 121 137 2-s2.0-77953444310 10.1177/1756283X09359964
7. Mouzaki M., Allard J., Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic. Annals of Gastroenterology 2012 25 3 207 217 2-s2.0-84863479772
8. Thounaojam M. C., Jadeja R. N., Devkar R. V., Ramachandran A. V., Non-alcoholic steatohepatitis: an overview including treatments with herbals as alternative therapeutics. Journal of Applied Biomedicine 2012 10 3 119 136
9. Neuschwander-Tetri B. A., Caldwell S. H., Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003 37 5 1202 1219 2-s2.0-0038644536 10.1053/jhep.2003.50193 (Pubitemid 36538699)
10. Nakajima K., Multidisciplinary pharmacotherapeutic options for nonalcoholic fatty liver disease. International Journal of Hepatology 2012 2012 13 950693 10.1155/2012/950693
11. Day C. P., James O. F. W., Steatohepatitis: a tale of two "Hits" Gastroenterology 1998 114 4 I 842 845 2-s2.0-0031947715 10.1016/S0016-5085(98)70599-2 (Pubitemid 28160420)
12. Cortez-Pinto H., de Moura M. C., Day C. P., Non-alcoholic steatohepatitis: from cell biology to clinical practice. Journal of Hepatology 2006 44 1 197 208 2-s2.0-28844459409 10.1016/j.jhep.2005.09.002 (Pubitemid 41772535)
13. Tilg H., Moschen A. R., Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010 52 5 1836 1846 2-s2.0-78049522194 10.1002/hep.24001
14. Bongiovanni M., Tordato F., Steatohepatitis in HIV-infected subjects: pathogenesis, clinical impact and implications in clinical management. Current HIV Research 2007 5 5 490 498 2-s2.0-35348888376
15. Takahashi Y., Soejima Y., Fukusato T., Animal models of nonalcoholic fatty liver disease/ nonalcoholic steatohepatitis. World Journal of Gastroenterology 2012 18 19 2300 2308 2-s2.0-84861738395 10.3748/wjg.v18.i19. 2300
16. Ninomiya M., Kondo Y., Shimosegawa T., Murine models of nonalcoholic fatty liver disease and steatohepatitis. ISRN Hepatology 2013 2013 7 237870 10.1155/2013/237870
17. Nakajima K., Multidisciplinary pharmacotherapeutic options for nonalcoholic fatty liver disease. International Journal of Hepatology 2012 2012 13 950693 10.1155/2012/950693
18. Chavez-Tapia N. C., Tellez-Avila F. I., Barrientos-Gutierrez T., Mendez-Sanchez N., Lizardi-Cervera J., Uribe M., Bariatric surgery for non-alcoholic steatohepatitis in obese patients. Cochrane Database of Systematic Reviews 2010 1 CD007340 2-s2.0-77649338357
19. Jadeja R. N., Thounaojam M. C., Dandekar D. S., Devkar R. V., Ramachandran A. V., Clerodendron glandulosum.Coleb extract ameliorates high fat diet/fatty acid induced lipotoxicity in experimental models of non-alcoholic steatohepatitis. Food and Chemical Toxicology 2010 48 12 3424 3431 2-s2.0-78049451156 10.1016/j.fct.2010.09.015
20. Jaya C., Anuradha C. V., Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet. Food and Chemical Toxicology 2010 48 8-9 2021 2029 2-s2.0-77955054237 10.1016/j.fct.2010.04.044
21. Xu Z.-J., Fan J.-G., Ding X.-D., Qiao L., Wang G.-L., Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats. Digestive Diseases and Sciences 2010 55 4 931 940 2-s2.0-77950355485 10.1007/s10620-009-0815-3
22. Oz H. S., Chen T. S., Neuman M., Methionine deficiency and hepatic injury in a dietary steatohepatitis model. Digestive Diseases and Sciences 2008 53 3 767 776 2-s2.0-39849106893 10.1007/s10620-007-9900-7 (Pubitemid 351317057)
23. Li Z., Yang S., Lin H., Huang J., Watkins P. A., Moser A. B., DeSimone C., Song X.-Y., Diehl A. M., Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003 37 2 343 350 2-s2.0-0037309589 10.1053/jhep.2003.50048 (Pubitemid 36152533)
24. Larter C. Z., Yeh M. M., Animal models of NASH: getting both pathology and metabolic context right. Journal of Gastroenterology and Hepatology 2008 23 11 1635 1648 2-s2.0-56549117448 10.1111/j.1440-1746.2008.05543.x
25. Nakayama H., Otabe S., Ueno T., Hirota N., Yuan X., Fukutani T., Hashinaga T., Wada N., Yamada K., Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis. Metabolism 2007 56 4 470 475 2-s2.0-33947264902 10.1016/j.metabol.2006.11.004 (Pubitemid 46427843)
26. Okumura K., Ikejima K., Kon K., Abe W., Yamashina S., Enomoto N., Takei Y., Sato N., Exacerbation of dietary steatohepatitis and fibrosis in obese, diabetic KK-Ay mice. Hepatology Research 2006 36 3 217 228 2-s2.0-33750070921 10.1016/j.hepres.2006.07.009 (Pubitemid 44575929)
27. Horie Y., Suzuki A., Kataoka E., Sasaki T., Hamada K., Sasaki J., Mizuno K., Hasegawa G., Kishimoto H., Iizuka M., Naito M., Enomoto K., Watanabe S., Mak T. W., Nakano T., Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. Journal of Clinical Investigation 2004 113 12 1774 1783 2-s2.0-3042848979 10.1172/JCI200420513 (Pubitemid 39071669)
28. Nagarajan P., Jerald Mahesh Kumar M., Venkatesan R., Majundar S. S., Juyal R. C., Genetically modified mouse models for the study of nonalcoholic fatty liver disease. World Journal of Gastroenterology 2012 18 11 1141 1153 2-s2.0-84858784269 10.3748/wjg.v18.i11.1141
29. Lu S. C., Alvarez L., Huang Z.-Z., Chen L., An W., Corrales F. J., Avila M. A., Kanel G., Mato J. M., Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proceedings of the National Academy of Sciences of the United States of America 2001 98 10 5560 5565 2-s2.0-0035826898 10.1073/pnas.091016398 (Pubitemid 32435681)
30. Asano T., Watanabe K., Kubota N., Gunji T., Omata M., Kadowaki T., Ohnishi S., Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis. Journal of Gastroenterology and Hepatology 2009 24 10 1669 1676 2-s2.0-70349678823 10.1111/j.1440-1746.2009.06039.x
31. Wueest S., Rapold R. A., Schumann D. M., Rytka J. M., Schildknecht A., Nov O., Chervonsky A. V., Rudich A., Schoenle E. J., Donath M. Y., Konrad D., Deletion of Fas in adipocytes relieves adipose tissue inflammation and hepatic manifestations of obesity in mice. Journal of Clinical Investigation 2010 120 1 191 202 2-s2.0-74949138985 10.1172/JCI38388
32. Ouchi N., Higuchi A., Ohashi K., Oshima Y., Gokce N., Shibata R., Akasaki Y., Shimono A., Walsh K., Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity. Science 2010 329 5990 454 457 2-s2.0-77954844177 10.1126/science.1188280
33. de Oliveira C. P. M. S., de Lima V. M. R., Simplicio F. I., Soriano F. G., de Mello E. S., de Souza H. P., Alves V. A. F., Laurindo F. R. M., Carrilho F. J., De Oliveira M. G., Prevention and reversion of nonalcoholic steatohepatitis in OB/OB mice by S-nitroso-N-acetylcysteine treatment. Journal of the American College of Nutrition 2008 27 2 299 305 2-s2.0-49649099007
34. Rinella M. E., Elias M. S., Smolak R. R., Fu T., Borensztajn J., Green R. M., Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. Journal of Lipid Research 2008 49 5 1068 1076 2-s2.0-50049097587 10.1194/jlr.M800042-JLR200
35. Carmiel-Haggai M., Cederbaum A. I., Nieto N., A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats. FASEB Journal 2005 19 1 136 138 2-s2.0-11244348954 10.1096/fj.04-2291fje (Pubitemid 40069943)
36. Schattenberg J. M., Wang Y., Singh R., Rigoli R. M., Czaja M. J., Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. Journal of Biological Chemistry 2005 280 11 9887 9894 2-s2.0-15444375341 10.1074/jbc.M410310200 (Pubitemid 40395836)
37. Wunderlich F. T., Luedde T., Singer S., Schmidt-Supprian M., Baumgartl J., Schirmacher P., Pasparakis M., Brüning J. C., Hepatic NF- B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 4 1297 1302 2-s2.0-39549101229 10.1073/pnas.0707849104 (Pubitemid 351397047)
38. Fu J.-H., Sun H.-S., Wang Y., Zheng W.-Q., Shi Z.-Y., Wang Q.-J., The effects of a fat- and sugar-enriched diet and chronic stress on nonalcoholic fatty liver disease in male wistar rats. Digestive Diseases and Sciences 2010 55 8 2227 2236 2-s2.0-77954427050 10.1007/s10620-009-1019-6
39. Bujanda L., Hijona E., Larzabal M., Beraza M., Aldazabal P., García-Urkia N., Sarasqueta C., Cosme A., Irastorza B., González A., Arenas J. I. Jr., Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterology 2008 8, article 40 2-s2.0-52749094256 10.1186/1471-230X-8-40
40. Rafiq N., Younossi Z. M., Effects of weight loss on nonalcoholic fatty liver disease. Seminars in Liver Disease 2008 28 4 427 433 2-s2.0-56649106415 10.1055/s-0028-1091986
41. Al-Busafi S. A., Wong P., Ghali P., Deschenes M., Antioxidant therapy in nonalcoholic steatohepatitis. Hepatitis Research and Treatment 2012 2012 8 947575 10.1155/2012/947575
42. Duseja A., Therapy of nonalcoholic steatohepatitis (NASH)-antioxidants and cytoprotective agents. Tropical Gastroenterology 2011 32 supplement 1 S33 S37
43. Stein L. L., Dong M. H., Loomba R., Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: current status. Advances in Therapy 2009 26 10 893 907 2-s2.0-73949147212 10.1007/s12325-009-0072-z
44. Nseir W., Mograbi J., Ghali M., Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies. Digestive Diseases and Sciences 2012 57 7 1773 1781 2-s2.0-84864290671 10.1007/s10620-012-2118-3
45. Guo H.-X., Liu D.-H., Ma Y., Liu J.-F., Wang Y., Du Z.-Y., Wang X., Shen J.-K., Peng H.-L., Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet. Acta Pharmacologica Sinica 2009 30 11 1505 1512 2-s2.0-70449370069 10.1038/aps.2009.150
46. Murase T., Misawa K., Minegishi Y., Aoki M., Ominami H., Suzuki Y., Shibuya Y., Hase T., Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. The American Journal of Physiology-Endocrinology and Metabolism 2011 300 1 E122 E133 2-s2.0-78650762536 10.1152/ajpendo.00441.2010
47. Kim E., Choi Y., Jang J., Park T., Carvacrol protects against hepatic steatosis in mice fed a high-fat diet by enhancing SIRT1-AMPK signaling. Evidence-Based Complementary and Alternative Medicine 2013 2013 10 2-s2.0-84874863636 10.1155/2013/290104 290104
48. Leclercq I. A., Farrell G. C., Sempoux C., Peña A. D., Horsmans Y., Curcumin inhibits NF- B activation and reduces the severity of experimental steatohepatitis in mice. Journal of Hepatology 2004 41 6 926 934 2-s2.0-9644295733 10.1016/j.jhep.2004.08.010 (Pubitemid 39575659)
49. Vizzutti F., Provenzano A., Galastri S., Milani S., Delogu W., Novo E., Caligiuri A., Zamara E., Arena U., Laffi G., Parola M., Pinzani M., Marra F., Curcumin limits the fibrogenic evolution of experimental steatohepatitis. Laboratory Investigation 2010 90 1 104 115 2-s2.0-73349133313 10.1038/labinvest.2009.112
50. Li J. M., Li Y. C., Kong L. D., Hu Q. H., Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology 2010 51 5 1555 1566
51. Bose M., Lambert J. D., Ju J., Reuhl K. R., Shapses S. A., Yang C. S., The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. Journal of Nutrition 2008 138 9 1677 1683 2-s2.0-51049094422
52. Ueno T., Torimura T., Nakamura T., Sivakumar R., Nakayama H., Otabe S., Yuan X., Yamada K., Hashimoto O., Inoue K., Koga H., Sata M., Epigallocatechin-3-gallate improves nonalcoholic steatohepatitis model mice expressing nuclear sterol regulatory element binding protein-1c in adipose tissue. International Journal of Molecular Medicine 2009 24 1 17 22 2-s2.0-67649522012 10.3892/ijmm-00000200
53. Bahcecioglu I. H., Kuzu N., Metin K., Ozercan I. H., Ustündag B., Sahin K., Kucuk O., Lycopene prevents development of steatohepatitis in experimental nonalcoholic steatohepatitis model induced by high-fat diet. Veterinary Medicine International 2010 2010 8 2-s2.0-84858175296 10.4061/2010/262179 262179
54. Chang C. J., Tzeng T.-F., Liou S.-S., Chang Y.-S., Liu I.-M., Myricetin increases hepatic peroxisome proliferator-activated receptor protein expression and decreases plasma lipids and adiposity in rats. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 2-s2.0-84859760154 10.1155/2012/787152 787152
55. Cho K. W., Kim Y. O., Andrade J. E., Burgess J. R., Kim Y.-C., Dietary naringenin increases hepatic peroxisome proliferators-activated receptor α protein expression and decreases plasma triglyceride and adiposity in rats. European Journal of Nutrition 2011 50 2 81 88 2-s2.0-79958276860 10.1007/s00394-010-0117-8
56. Park S., Choi Y., Um S.-J., Yoon S. K., Park T., Oleuropein attenuates hepatic steatosis induced by high-fat diet in mice. Journal of Hepatology 2011 54 5 984 993 2-s2.0-79954860748 10.1016/j.jhep.2010.08.019
57. Jwa H., Choi Y., Park U.-H., Um S.-J., Yoon S. K., Park T., Piperine, an LXR α antagonist, protects against hepatic steatosis and improves insulin signaling in mice fed a high-fat diet. Biochemical Pharmacology 2012 84 11 1501 1510 2-s2.0-84868461692 10.1016/j.bcp.2012.09.009
58. Marcolin E., San-Miguel B., Vallejo D., Tieppo J., Marroni N., González-Gallego J., Tuñón M. J., Quercetin treatment ameliorates inflammation and fibrosis in mice with nonalcoholic steatohepatitis. Journal of Nutrition 2012 142 10 1821 1828 2-s2.0-84869121923 10.3945/jn.112.165274
59. Marcolin É., Forgiarini L. F., Rodrigues G., Tieppo J., Borghetti G. S., Bassani V. L., Picada J. N., Marroni N. P., Quercetin decreases liver damage in mice with non-alcoholic steatohepatitis. Basic and Clinical Pharmacology and Toxicology 2013 112 6 385 391 2-s2.0-84878146773 10.1111/bcpt.12049
60. Ying H.-Z., Liu Y.-H., Yu B., Wang Z.-Y., Zang J.-N., Yu C.-H., Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. Food and Chemical Toxicology 2013 52 53 60 2-s2.0-84869869189 10.1016/j.fct.2012.10.030
61. Shang J., Chen L.-L., Xiao F.-X., Sun H., Ding H.-C., Xiao H., Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharmacologica Sinica 2008 29 6 698 706 2-s2.0-44849131936 10.1111/j.1745-7254.2008.00807.x (Pubitemid 351799479)
62. Panchal S. K., Poudyal H., Arumugam T. V., Brown L., Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. Journal of Nutrition 2011 141 6 1062 1069 2-s2.0-79958211266 10.3945/jn.111.137877
63. Kim M., Yang S.-G., Kim J. M., Lee J.-W., Kim Y. S., Lee J. I., Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells. International Journal of Molecular Medicine 2012 30 3 473 479 2-s2.0-84865176650 10.3892/ijmm.2012.1029
64. Luo X.-Y., Takahara T., Hou J., Kawai K., Sugiyama T., Tsukada K., Takemoto M., Takeuchi M., Zhong L., Li X.-K., Theaflavin attenuates ischemia-reperfusion injury in a mouse fatty liver model. Biochemical and Biophysical Research Communications 2012 417 1 287 293 2-s2.0-84855775173 10.1016/j.bbrc.2011.11.102
65. Song H.-Y., Mao Z.-M., Yang L.-L., Liu T., Li D.-F., Zhang L., Ge Y.-L., Zheng P.-Y., Liu P., Zhang X.-Q., Ji G., Dangfei liganning capsules attenuate the susceptibility of rat nonalcoholic fatty liver to carbon tetrachloride toxicity. Journal of Traditional Chinese Medicine 2011 31 4 327 333 2-s2.0-84860619106
66. Ji G., Fan J.-G., Chen J.-J., Lu L.-G., Xing L.-J., Zheng P.-Y., Gu H.-G., Wei H.-F., You S.-F., Zhu P.-T., Effectiveness of Danning Tablet in patients with non-alcoholic fatty liver of damp-heat syndrome type: a multicenter randomized controlled trial. Zhong Xi Yi Jie He Xue Bao 2008 6 2 128 133 2-s2.0-39149134614 10.3736/jcim20080205 (Pubitemid 351255890)
67. Jia Y.-H., Wang R.-Q., Mi H.-M., Kong L.-B., Ren W.-G., Li W.-C., Zhao S.-X., Zhang Y.-G., Wu W.-J., Nan Y.-M., Yu J., Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice. Lipids in Health and Disease 2012 11, article 45 2-s2.0-84858963189 10.1186/1476-511X-11-45
68. Fujimoto M., Tsuneyama K., Kainuma M., Sekiya N., Goto H., Takano Y., Terasawa K., Selmi C., Gershwin M. E., Shimada Y., Evidence-based efficacy of kampo formulas in a model of non alcoholic fatty liver. Experimental Biology and Medicine 2008 233 3 328 337 2-s2.0-40149085740 10.3181/0707-RM-207 (Pubitemid 351328574)
69. Suriyavathana Vedanarayanan M., Krishnan N., Ayurvedic formulation of Liv-Pro-08 reduces nonalcoholic fatty liver disease in rats fed with high-fat diet. Journal of Acupuncture and Meridian Studies 2011 4 4 236 241 2-s2.0-84155165537 10.1016/j.jams.2011.09.014
70. Yang S.-Y., Zhao N.-J., Li X.-J., Zhang H.-J., Chen K.-J., Li C.-D., Ping-tang recipe improves insulin resistance and attenuates hepatic steatosis in high-fat diet-induced obese rats. Chinese Journal of Integrative Medicine 2012 18 4 262 268 2-s2.0-84862736174 10.1007/s11655-012-1023-0
71. Li L., Zhang X.-J., Lan Y., Xu L., Zhang X.-Z., Wang H.-H., Treatment of non-alcoholic fatty liver disease by Qianggan capsule. Chinese Journal of Integrative Medicine 2010 16 1 23 27 2-s2.0-76649097052 10.1007/s11655-010-0023- 1
72. Li H.-S., Feng Q., Xu L.-L., Chen S.-D., Li X.-M., Hu Y.-Y., Effects of Qushi Huayu Decoction in prevention and treatment of fatty liver in rats based on adiponection-free fatty acid pathway. Zhong Xi Yi Jie He Xue Bao 2009 7 6 546 551 2-s2.0-72849106154 10.3736/jcim20090610
73. Zhang H., Feng Q., Li H.-S., Chen S.-D., Wang X.-N., Peng J.-H., Zhang N., Hu Y.-Y., Effects of Qushi Huayu Decoction on cathepsin B and tumor necrosis factor- α expression in rats with non-alcoholic steatohepatitis. Zhong Xi Yi Jie He Xue Bao 2008 6 9 928 933 2-s2.0-52949139785 10.3736/jcim20080910
74. Kang J. S., Lee W. K., Yoon W. K., Kim N., Park S.-K., Park H. K., Ly S. Y., Han S.-B., Yun J., Lee C. W., Lee K., Lee K. H., Park S.-K., Kim H. M., A combination of grape extract, green tea extract and l -carnitine improves high-fat diet-induced obesity, hyperlipidemia and non-alcoholic fatty liver disease in mice. Phytotherapy Research 2011 25 12 1789 1795 2-s2.0-82155201715 10.1002/ptr.3476
75. Kang J. S., Lee W. K., Lee C. W., Yoon W. K., Kim N., Park S.-K., Lee H.-S., Park H. K., Han S.-B., Yun J., Lee K., Lee K. H., Park S.-K., Kim H. M., Improvement of high-fat diet-induced obesity by a mixture of red grape extract, soy isoflavone and l-carnitine: implications in cardiovascular and non-alcoholic fatty liver diseases. Food and Chemical Toxicology 2011 49 9 2453 2458 2-s2.0-79960847322 10.1016/j.fct.2011.06.071
76. Zhang Q., Zhao Y., Zhang D.-B., Sun L.-J., Effect of Sinai San decoction on the development of non-alcoholic steatohepatitis in rats. World Journal of Gastroenterology 2005 11 9 1392 1395 2-s2.0-15844415299 (Pubitemid 40425928)
77. Gu C.-L., Zhang Y.-K., Fu Y.-X., Yang S.-F., Li X.-Q., Effect of Tiaozhi Yanggan Decoction in treating patients with non-alcoholic fatty liver. Chinese Journal of Integrative Medicine 2007 13 4 275 279 2-s2.0-37549050122 10.1007/s11655-007-0275-6
78. Chen S.-D., Fan Y., Xu W.-J., Effects of Yinchenhao Decoction for non-alcoholic steatohepatitis in rats and study of the mechanism. Journal of Traditional Chinese Medicine 2011 31 3 220 223 2-s2.0-80053558945
79. Chande N., Laidlaw M., Adams P., Marotta P., Yo Jyo Hen Shi Ko (YHK) improves transaminases in nonalcoholic steatohepatitis (NASH): a randomized pilot study. Digestive Diseases and Sciences 2006 51 7 1183 1189 2-s2.0-33748435506 10.1007/s10620-006-8030-y (Pubitemid 44341517)
80. Vermaak I., Viljoen A. M., Hamman J. H., Natural products in anti-obesity therapy. Natural Product Reports 2011 28 9 1493 1533 2-s2.0-80052082199 10.1039/c1np00035g
81. Liu T.-P., Lee C.-S., Liou S.-S., Liu I.-M., Cheng J.-T., Improvement of insulin resistance by Acanthopanax senticosus root in fructose-rich chow-fed rats. Clinical and Experimental Pharmacology and Physiology 2005 32 8 649 654 2-s2.0-22644445542 10.1111/j.0305-1870.2005.04245.x (Pubitemid 41025827)
82. Fu J., Fu J., Yuan J., Zhang N., Gao B., Fu G., Tu Y., Zhang Y., Anti-diabetic activities of Acanthopanax senticosus polysaccharide (ASP) in combination with metformin. International Journal of Biological Macromolecules 2012 50 3 619 623 2-s2.0-84863282547 10.1016/j.ijbiomac.2012.01.034
83. Cha Y.-S., Rhee S.-J., Heo Y.-R., Acanthopanax senticosus extract prepared from cultured cells decreases adiposity and obesity indices in C57BL/6J mice fed a high fat diet. Journal of Medicinal Food 2004 7 4 422 429 2-s2.0-11844294620 (Pubitemid 40095841)
84. Park S. H., Lee S. G., Kang S. K., Chung S. H., Acanthopanax senticosus reverses fatty liver disease and hyperglycemia in ob/ob mice. Archives of Pharmacal Research 2006 29 9 768 776 2-s2.0-33749364335 (Pubitemid 44496458)
85. Hong X., Tang H., Wu L., Li A., Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease. Journal of Pharmacy and Pharmacology 2006 58 10 1391 1398 2-s2.0-33750067702 10.1211/jpp.57.10.0013 (Pubitemid 44580570)
86. Yang X. B., Huang Z. M., Effects of rhizome alismatis extract on blood glucose in normal and diabetes. Pharmacology and Clinics of Chinese Materia Medica 2004 14 19 23
87. Yang X.-B., Huang Z.-M., Cao W.-B., Chen W., Tao J.-H., Chen H.-Y., Tian W.-H., Wang J.-H., Effects of rhizome alismatis extract on blood biochemical indices and insulin in hyperglycemic mice. Chinese Journal of Clinical Rehabilitation 2004 8 6 1196 1197 2-s2.0-2442419662 (Pubitemid 38637267)
88. Bruno R. S., Dugan C. E., Smyth J. A., DiNatale D. A., Koo S. I., Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury. Journal of Nutrition 2008 138 2 323 331 2-s2.0-38949165468 (Pubitemid 351213647)
89. Kuzu N., Bahcecioglu I. H., Dagli A. F., Ozercan I. H., Ustündag B., Sahin K., Epigallocatechin gallate attenuates experimental non-alcoholic steatohepatitis induced by high fat diet. Journal of Gastroenterology and Hepatology 2008 23 8 e465 e470 2-s2.0-48549096915 10.1111/j.1440-1746.2007. 05052.x
90. Nakamoto K., Takayama F., Mankura M., Hidaka Y., Egashira T., Ogino T., Kawasaki H., Mori A., Beneficial effects of fermented green tea extract in a rat model of non-alcoholic steatohepatitis. Journal of Clinical Biochemistry and Nutrition 2009 44 3 239 246 2-s2.0-68549125103 10.3164/jcbn.08-256
91. Viswanatha Swamy A. H. M., Kulkarni R. V., Thippeswamy A. H. M., Koti B. C., Gore A., Evaluation of hepatoprotective activity of Cissus quadrangularis stem extract against isoniazid-induced liver damage in rats. Indian Journal of Pharmacology 2010 42 6 397 400 2-s2.0-78149384150 10.4103/0253-7613.71920
92. Sen M. K., Dash B. K., A review on phytochemical and pharmacological aspects of Cissus quadrangularis L. International Journal of Green Pharmacy 2012 6 3 169 173 2-s2.0-84871901616 10.4103/0973-8258.104924
93. Chidambaram J., Carani Venkatraman A., Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet. Food and Chemical Toxicology 2010 48 8-9 2021 2029 2-s2.0-77955054237 10.1016/j.fct.2010.04.044
94. Chidambaram J., Vetriselvi V., Carani Venkatraman A., Inflammatory responses in liver induced by high fat plus fructose diet: therapeutic potential of cissus quadrangularis stem. International Journal Of Biological and Medical Research 2010 1 4 120 124
95. Jadeja R. N., Thounaojam M. C., Singh T. B., Devkar R. V., Ramachandran A., Traditional uses, phytochemistry and pharmacology of Clerodendron glandulosum Coleb-a review. Asian Pacific Journal of Tropical Medicine 2012 5 1 1 6 2-s2.0-84857137037
96. Kala C. P., Ethnomedicinal botany of the Apatani in the Eastern Himalayan region of India. Journal of Ethnobiology and Ethnomedicine 2005 1, article 11 2-s2.0-34247589507 10.1186/1746-4269-1-11
97. Deb S., Arunachalam A., Das A. K., Indigenous knowledge of Nyishi tribes on traditional agroforestry systems. Indian Journal of Traditional Knowledge 2009 8 1 41 46 2-s2.0-78649392263
98. Purkayastha J., Nath S. C., Islam M., Ethnobotany of medicinal plants from Dibru-Saikhowa Biosphere Reserve of Northeast India. Fitoterapia 2005 76 1 121 127 2-s2.0-12344251922 10.1016/j.fitote.2004.10.012 (Pubitemid 40139016)
99. Jadeja R. N., Thounaojam M. C., Devkar R. V., Ramachandran A. V., A preliminary study on hypolipidemic effect of aqueous leaf extract of Clerodendron glandulosum.Coleb. International Journal of Green Pharmacy 2009 3 4 285 289 2-s2.0-77953391252 10.4103/0973-8258.59733
100. Jadeja R. N., Thounaojam M. C., Devkar R. V., Ramachandran A. V., Clerodendron glandulosum Coleb., Verbenaceae, ameliorates high fat diet-induced alteration in lipid and cholesterol metabolism in rats. Brazilian Journal of Pharmacognosy 2010 20 1 117 123 2-s2.0-77953859843
101. Jadeja R. N., Thounaojam M. C., Patel V. B., Devkar R. V., Ramachandran A. V., Protective effect of Clerodendron glandulosum extract against experimentally induced metabolic syndrome in rats. Pharmaceutical Biology 2010 48 12 1312 1319 2-s2.0-78649342759 10.3109/13880201003739304
102. Jadeja R. N., Thounaojam M. C., Ramani U. V., Devkar R. V., Ramachandran A. V., Anti-obesity potential of Clerodendron glandulosum.Coleb leaf aqueous extract. Journal of Ethnopharmacology 2011 135 2 338 343 2-s2.0-79955678314 10.1016/j.jep.2011.03.020
103. Jadeja R. N., Thounaojam M. C., Jadav S. V., Patel M. D., Patel D. K., Salunke S. P., Padate G. S., Devkar R. V., Ramachandran A. V., Toxicological evaluation and hepatoprotective potential of Clerodendron glandulosum.Coleb leaf extract. Human and Experimental Toxicology 2011 30 1 63 70 2-s2.0-78650215323 10.1177/0960327110368420
104. Curcuma longa (turmeric). Monograph. Alternative Medicine Review 2001 6 supplement S62 S66
105. Alappat L., Awad A. B., Curcumin and obesity: evidence and mechanisms. Nutrition Reviews 2010 68 12 729 738 2-s2.0-78649422311 10.1111/j.1753-4887. 2010.00341.x
106. Kaffashi Elahi R., Preventive effects of turmeric (Curcuma longa Linn.) powder on hepatic steatosis in the rats fed with high fat diet. Life Science Journal 2012 9 4 5462 5468 2-s2.0-84877049792
107. Yiu W.-F., Kwan P.-L., Wong C.-Y., Kam T.-S., Chiu S.-M., Chan S.-W., Chan R., Attenuation of fatty liver and prevention of hypercholesterolemia by extract of Curcuma longa through regulating the expression of CYP7A1, LDL-receptor, HO-1, and HMG-CoA reductase. Journal of Food Science 2011 76 3 H80 H89 2-s2.0-79954992709 10.1111/j.1750-3841.2011.02042.x
108. Asai A., Miyazawa T., Dietary curcuminoids prevent high-fat diet-induced lipid accumulation in rat liver and epididymal adipose tissue. Journal of Nutrition 2001 131 11 2932 2935 2-s2.0-0035171859 (Pubitemid 33063126)
109. Leclercq I. A., Farrell G. C., Sempoux C., Peña A. D., Horsmans Y., Curcumin inhibits NF- B activation and reduces the severity of experimental steatohepatitis in mice. Journal of Hepatology 2004 41 6 926 934 2-s2.0-9644295733 10.1016/j.jhep.2004.08.010 (Pubitemid 39575659)
110. Oh J., Min O.-J., Kim H.-A., Kim Y. J., Baek H. Y., Rhyu D. Y., Effect of Eriobotrya japonica on adipogenesis and body weight. Journal of Applied Biological Chemistry 2011 54 3 382 387 2-s2.0-79960512474 10.3839/jksabc.2011. 060
111. Tanaka K., Nishizono S., Makino N., Tamaru S., Terai O., Ikeda I., Hypoglycemic activity of Eriobotrya japonica seeds in type 2 diabetic rats and mice. Bioscience, Biotechnology and Biochemistry 2008 72 3 686 693 2-s2.0-41549101122 10.1271/bbb.70411 (Pubitemid 351463683)
112. Singh M., Jain C. K., Mathur A., Phyto-pharmacological potential of Ginkgo biloba: a review. Journal of Pharmacy Research 2012 5 10 5028 5030
113. Cong W T. R., Tian J., Zhao J., Liu Q., Ye F., EGb761, an extract of Ginkgo biloba leaves, reduces insulin resistance in a high-fat-fed mouse model. Acta Pharmaceutica Sinica 2011 1 1 14 20
114. Xia J., Zhang X., Ye X., Liu J., Wang L., Zhong Y., Intervention study of Ginkgo biloba extract in rat model of lipid-induced insulin resistance. Journal of Medicinal Plant Research 2011 5 27 6284 6290 2-s2.0-82855181217 10.5897/JMPR11.413
115. Wang S. D., Xie Z. Q., Chen J., Wang K., Wei T., Zhao A. H., Zhang Q. H., Inhibitory effect of ginkgo biloba extract on fatty liver: regulation of carnitine palmitoyltransferase 1a and fatty acid metabolism. Journal of Digestive Diseases 2012 13 10 525 535 2-s2.0-84866464218 10.1111/j.1751-2980. 2012.00627.x
116. Elshal M. F., Abulnaja K. O., Influence of defatted flaxseed diet on insulin sensitivity, vascular permeability and lipid profile in a rat model of type 2 diabetes mellitus. Journal of Medicinal Plants Research 2012 6 11 2188 2193
117. Rhee Y., Brunt A., Flaxseed supplementation improved insulin resistance in obese glucose intolerant people: a randomized crossover design. Nutrition Journal 2011 10 1, article 44 2-s2.0-79955695959 10.1186/1475-2891-10-44
118. Fukumitsu S., Aida K., Shimizu H., Toyoda K., Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men. Nutrition Research 2010 30 7 441 446 2-s2.0-77955936575 10.1016/j.nutres.2010.06.004
119. Kristensen M., Jensen M. G., Aarestrup J., Petersen K. E. N., Søndergaard L., Mikkelsen M. S., Astrup A., Flaxseed dietary fibers lower cholesterol and increase fecal fat excretion, but magnitude of effect depend on food type. Nutrition & Metabolism 2012 9, article 8 2-s2.0-84856454675 10.1186/1743-7075-9-8
120. Yang S.-F., Tseng J.-K., Chang Y.-Y., Chen Y.-C., Flaxseed oil attenuates nonalcoholic fatty liver of hyperlipidemic hamsters. Journal of Agricultural and Food Chemistry 2009 57 11 5078 5083 2-s2.0-67149123675 10.1021/jf900499v
121. Mukherjee P. K., Mukherjee D., Maji A. K., Rai S., Heinrich M., The sacred lotus (Nelumbo nucifera)-phytochemical and therapeutic profile. Journal of Pharmacy and Pharmacology 2009 61 4 407 422 2-s2.0-66449094653 10.1211/jpp/61.04.0001
122. Xie B., Wan J., Wang W. Q., Shi C. Y., Hou X. L., Fang J. G., Nelumbo nucifera alkaloid inhibits 3T3-L1 preadipocyte differentiation and improves high-fat diet-induced obesity and body fat accumulation in rats. Journal of Medicinal Plants Research 2011 5 10 2021 2028 2-s2.0-84860408556
123. Ono Y., Hattori E., Fukaya Y., Imai S., Ohizumi Y., Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. Journal of Ethnopharmacology 2006 106 2 238 244 2-s2.0-33646773975 10.1016/j.jep.2005.12. 036 (Pubitemid 43766196)
124. Wu C.-H., Yang M.-Y., Chan K.-C., Chung P.-J., Ou T.-T., Wang C.-J., Improvement in high-fat diet-induced obesity and body fat accumulation by a nelumbo nucifera leaf flavonoid-rich extract in mice. Journal of Agricultural and Food Chemistry 2010 58 11 7075 7081 2-s2.0-77953143747 10.1021/jf101415v
125. Tsuruta Y., Nagao K., Shirouchi B., Nomura S., Tsuge K., Koganemaru K., Yanagita T., Effects of lotus root (the edible rhizome of nelumbo nucifera) on the deveolopment of non-alcoholic fatty liver disease in obese diabetic db/db mice. Bioscience, Biotechnology and Biochemistry 2012 76 3 462 466 2-s2.0-84859011499 10.1271/bbb.110745
126. Tsuruta Y., Nagao K., Kai S., Tsuge K., Yoshimura T., Koganemaru K., Yanagita T., Polyphenolic extract of lotus root (edible rhizome of Nelumbo nucifera) alleviates hepatic steatosis in obese diabetic db/db mice. Lipids in Health and Disease 2011 10, article 202 2-s2.0-80655139138 10.1186/1476-511X-10- 202
127. Ghanbari R., Anwar F., Alkharfy K. M., Gilani A.-H., Saari N., Valuable nutrients and functional bioactives in different parts of olive (Olea europaea L.)-a review. International Journal of Molecular Sciences 2012 13 3 1291 1340 2-s2.0-84858966810 10.3390/ijms13033291
128. Pérez-Martínez P., García-Ríos A., Delgado-Lista J., Pérez-Jiménez F., López-Miranda J., Mediterranean diet rich in olive oil and obesity, metabolic syndrome and diabetes mellitus. Current Pharmaceutical Design 2011 17 8 769 777 2-s2.0-79958213712 10.2174/138161211795428948
129. Huang S.-T., Pang J.-H. S., Yang R.-C., Anti-cancer effects of Phyllanthus urinaria and relevant mechanisms. Chang Gung Medical Journal 2010 33 5 477 487 2-s2.0-78249282258
130. Poudyal H., Campbell F., Brown L., Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. Journal of Nutrition 2010 140 5 946 953 2-s2.0-77951486280 10.3945/jn.109.117812
131. Omagari K., Kato S., Tsuneyama K., Hatta H., Sato M., Hamasaki M., Sadakane Y., Tashiro T., Fukuhata M., Miyata Y., Tamaru S., Tanaka K., Mune M., Olive leaf extract prevents spontaneous occurrence of non-alcoholic steatohepatitis in SHR/NDmcr-cp rats. Pathology 2010 42 1 66 72 2-s2.0-73649112765 10.3109/00313020903434389
132. Garg Munish G. C., Effect of phyllanthus urinaria in biochemical profile of experimental hyperglycemic albino rats. Research Journal of Pharmaceutical Sciences 2012 1 1 2 6
133. Shen B., Yu J., Wang S., Chu E. S. H., Wong V. W. S., Zhou X., Lin G., Sung J. J. Y., Chan H. L. Y., Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo. Hepatology 2008 47 2 473 483 2-s2.0-39549108872 10.1002/hep.22039 (Pubitemid 351280715)
134. Picrorhiza kurroa. Monograph. Alternative Medicine Review 2001 6 3 319 321
135. Joy K. L., Kuttan R., Anti-diabetic activity of Picrorrhiza kurroa extract. Journal of Ethnopharmacology 1999 67 2 143 148 2-s2.0-0032861574 10.1016/S0378-8741(98)00243-8 (Pubitemid 29421668)
136. Lee H.-S., Ku S.-K., Effect of Picrorrhiza rhizoma extracts on early diabetic nephropathy in streptozotocin-induced diabetic rats. Journal of Medicinal Food 2008 11 2 294 301 2-s2.0-46749098344 10.1089/jmf.2007.578 (Pubitemid 351948177)
137. Lee H. S., Yoo C. B., Ku S. K., Hypolipemic effect of water extracts of Picrorrhiza kurroa in high fat diet treated mouse. Fitoterapia 2006 77 7-8 579 584 2-s2.0-33750960087 10.1016/j.fitote.2006.09.004 (Pubitemid 44738284)
138. Husain G. M., Singh P. N., Kumar V., Antidiabetic activity of standardized extract of Picrorhiza kurroa in rat model of NIDDM. Drug Discoveries & Therapeutics 2009 3 3 88 92
139. Shetty S. N., Mengi S., Vaidya R., Vaidya A. D. B., A study of standardized extracts of Picrorhiza kurroa Royle ex Benth in experimental nonalcoholic fatty liver disease. Journal of Ayurveda and Integrative Medicine 2010 1 3 203 210 2-s2.0-79952903496 10.4103/0975-9476.72622
140. Han L.-K., Xu B.-J., Kimura Y., Zheng Y.-N., Okuda H., Platycodi radix affects lipid metabolism in mice with high fat diet-induced obesity. Journal of Nutrition 2000 130 11 2760 2764 2-s2.0-0033735626
141. Kim K.-S., Seo E.-K., Lee Y.-C., Lee T.-K., Cho Y.-W., Ezaki O., Kim C.-H., Effect of dietary Platycodon grandiflorum on the improvement of insulin resistance in obese Zucker rats. Journal of Nutritional Biochemistry 2000 11 9 420 424 2-s2.0-0033696628 10.1016/S0955-2863(00)00098-X
142. Noh J.-R., Kim Y.-H., Gang G.-T., Yang K.-J., Kim S.-K., Ryu S.-Y., Kim Y.-S., Lee C.-H., Lee H.-S., Preventative effects of Platycodon grandiflorum treatment on hepatic steatosis in high fat diet-fed C57BL/6 mice. Biological and Pharmaceutical Bulletin 2010 33 3 450 454 2-s2.0-77649225535 10.1248/bpb.33.450
143. Jurenka J., Therapeutic applications of pomegranate (Punica granatum L.): a review. Alternative Medicine Review 2008 13 2 128 144 2-s2.0-47549111139 (Pubitemid 352009502)
144. Wang J., Rong X., Um I. S. I., Yamahara J., Li Y., 55-week treatment of mice with the Unani and Ayurvedic medicine pomegranate flower ameliorates ageing-associated insulin resistance and skin abnormalities. Evidence-Based Complementary and Alternative Medicine 2012 2012 8 2-s2.0-84862955061 10.1155/2012/350125 350125
145. Jafri M. A., Aslam M., Javed K., Singh S., Effect of Punica granatum Linn. (flowers) on blood glucose level in normal and alloxan-induced diabetic rats. Journal of Ethnopharmacology 2000 70 3 309 314 2-s2.0-0034662490 10.1016/S0378-8741(99)00170-1 (Pubitemid 30317369)
146. Huang T. H. W., Peng G., Kota B. P., Li G. Q., Yamahara J., Roufogalis B. D., Li Y., Anti-diabetic action of Punica granatum flower extract: activation of PPAR- γ and identification of an active component. Toxicology and Applied Pharmacology 2005 207 2 160 169 2-s2.0-23044467570 10.1016/j.taap.2004. 12.009 (Pubitemid 41133502)
147. Huang T. H.-W., Peng G., Kota B. P., Li G. Q., Yamahara J., Roufogalis B. D., Li Y., Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids. British Journal of Pharmacology 2005 145 6 767 774 2-s2.0-23044510556 10.1038/sj.bjp.0706245 (Pubitemid 41076283)
148. Li Y., Wen S., Kota B. P., Peng G., Li G. Q., Yamahara J., Roufogalis B. D., Punica granatum flower extract, a potent α -glucosidase inhibitor, improves postprandial hyperglycemia in Zucker diabetic fatty rats. Journal of Ethnopharmacology 2005 99 2 239 244 2-s2.0-19444377479 10.1016/j.jep.2005.02.030 (Pubitemid 40724399)
149. Bagri P., Ali M., Aeri V., Bhowmik M., Sultana S., Antidiabetic effect of Punica granatum flowers: effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetes. Food and Chemical Toxicology 2009 47 1 50 54 2-s2.0-58149187862 10.1016/j.fct.2008.09.058
150. Xu K. Z.-Y., Zhu C., Kim M. S., Yamahara J., Li Y., Pomegranate flower ameliorates fatty liver in an animal model of type 2 diabetes and obesity. Journal of Ethnopharmacology 2009 123 2 280 287 2-s2.0-67349248083 10.1016/j.jep.2009.03.035
151. Li Y., Peng G., Li Q., Wen S., Hsun-Wei Huang T., Roufogalis B. D., Yamahara J., Salacia oblonga improves cardiac fibrosis and inhibits postprandial hyperglycemia in obese zucker rats. Life Sciences 2004 75 14 1735 1746 2-s2.0-3242741012 10.1016/j.lfs.2004.04.013 (Pubitemid 38961797)
152. Hsun-Wei Huang T., Peng G., Qian Li G., Yamahara J., Roufogalis B. D., Li Y., Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR- α Toxicology and Applied Pharmacology 2006 210 3 225 235 2-s2.0-30844432203 10.1016/j.taap.2005.05.003 (Pubitemid 43107565)
153. Thounaojam M. C., Jadeja R. N., Devkar R. V., Ramachandran A. V., Prevention of high fat diet induced insulin resistance in C57BL/6J mice by Sida rhomboidea ROXB. extract. Journal of Health Science 2010 56 1 92 98 2-s2.0-76249111831 10.1248/jhs.56.92
154. Thounaojam M. C., Jadeja R. N., Ramani U. V., Devkar R. V., Ramachandran A. V., Sida rhomboidea. Roxb leaf extract down-regulates expression of PPAR γ 2 and leptin genes in high fat diet fed C57BL/6J mice and retards in vitro 3T3L1 pre-adipocyte differentiation. International Journal of Molecular Sciences 2011 12 7 4661 4677 2-s2.0-79960767451 10.3390/ijms12074661
155. Thounaojam M. C., Jadeja R. N., Salunke S. P., Devkar R. V., Ramachandran A. V., Sida rhomboidea.Roxb aqueous extract down-regulates in vivo expression of vascular cell adhesion molecules in atherogenic rats and inhibits in vitro macrophage differentiation and foam cell formation. Immunopharmacology and Immunotoxicology 2012 34 5 832 843 2-s2.0-84866235613 10.3109/08923973.2012. 663386
156. Thounaojam M. C., Jadeja R. N., Dandekar D. S., Devkar R. V., Ramachandran A. V., Sida rhomboidea.Roxb extract alleviates pathophysiological changes in experimental in vivo and in vitro models of high fat diet/fatty acid induced non-alcoholic steatohepatitis. Experimental and Toxicologic Pathology 2012 64 3 217 224 2-s2.0-84856991718 10.1016/j.etp.2010.08.009
157. Haddad Y., Vallerand D., Brault A., Haddad P. S., Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis. Evidence-based Complementary and Alternative Medicine 2011 2011 10 2-s2.0-79952159257 10.1093/ecam/nep164 647903
158. Serviddio G., Bellanti F., Giudetti A. M., Gnoni G. V., Petrella A., Tamborra R., Romano A. D., Rollo T., Vendemiale G., Altomare E., A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis. Journal of Pharmacology and Experimental Therapeutics 2010 332 3 922 932 2-s2.0-77249113410 10.1124/jpet.109.161612
159. Amini R., Nosrati N., Yazdanparast R., Molaei M., Teucrium polium in prevention of steatohepatitis in rats. Liver International 2009 29 8 1216 1221 2-s2.0-70350072477 10.1111/j.1478-3231.2009.02033.x
160. Amini R., Yazdanparast R., Aghazadeh S., Ghaffari S. H., Teucrium polium reversed the MCD diet-induced liver injury in rats. Human and Experimental Toxicology 2011 30 9 1303 1312 2-s2.0-79960877031 10.1177/0960327110388961
161. Aghazadeh S., Yazdanparast R., Inhibition of JNK along with activation of ERK1/2 MAPK pathways improve steatohepatitis among the rats. Clinical Nutrition 2010 29 3 381 385 2-s2.0-77953539052 10.1016/j.clnu.2009.08.014
162. Starakis I., Siagris D., Leonidou L., Mazokopakis E., Tsamandas A., Karatza C., Hepatitis caused by the herbal remedy Teucrium polium L. European Journal of Gastroenterology and Hepatology 2006 18 6 681 683 2-s2.0-33744486602 (Pubitemid 43804653)
163. Savvidou S., Goulis J., Giavazis I., Patsiaoura K., Hytiroglou P., Arvanitakis C., Herb-induced hepatitis by Teucrium polium L.: report of two cases and review of the literature. European Journal of Gastroenterology and Hepatology 2007 19 6 507 511 2-s2.0-34248228183 10.1097/01.meg.0000252634.26538. eb (Pubitemid 46725758)
164. Chrubasik S., Pittler M. H., Roufogalis B. D., Zingiberis rhizoma: a comprehensive review on the ginger effect and efficacy profiles. Phytomedicine 2005 12 9 684 701 2-s2.0-23844530273 10.1016/j.phymed.2004.07.009 (Pubitemid 41169818)
165. Akhani S. P., Vishwakarma S. L., Goyal R. K., Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats. Journal of Pharmacy and Pharmacology 2004 56 1 101 105 2-s2.0-1042292667 10.1211/0022357022403 (Pubitemid 38195334)
166. Sivakumar V., Sivakumar S., Effect of an indigenous herbal compound preparation 'Trikatu' on the lipid profiles of atherogenic diet and standard diet fed Rattus norvegicus. Phytotherapy Research 2004 18 12 976 981 2-s2.0-14044257722 10.1002/ptr.1586 (Pubitemid 40278921)
167. Mascolo N., Jain R., Jain S. C., Capasso F., Ethnopharmacologic investigation of ginger (Zingiber officinale). Journal of Ethnopharmacology 1989 27 1-2 129 140 2-s2.0-0024791488 10.1016/0378-8741(89)90085-8 (Pubitemid 20018068)
168. Kar A., Choudhary B. K., Bandyopadhyay N. G., Comparative evaluation of hypoglycaemic activity of some Indian medicinal plants in alloxan diabetic rats. Journal of Ethnopharmacology 2003 84 1 105 108 2-s2.0-0037216916 10.1016/S0378-8741(02)00144-7 (Pubitemid 36040359)
169. Al-Amin Z. M., Thomson M., Al-Qattan K. K., Peltonen-Shalaby R., Ali M., Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats. British Journal of Nutrition 2006 96 4 660 666 2-s2.0-33947274715 10.1079/BJN20061849 (Pubitemid 46470189)
170. Goyal R. K., Kadnur S. V., Beneficial effects of Zingiber officinale on goldthioglucose induced obesity. Fitoterapia 2006 77 3 160 163 2-s2.0-33646086967 10.1016/j.fitote.2006.01.005
171. Han L.-K., Gong X.-J., Kawano S., Saito M., Kimura Y., Okuda H., Antiobesity actions of Zingiber officinale Roscoe. Yakugaku Zasshi 2005 125 2 213 217 2-s2.0-17244368760 10.1248/yakushi.125.213 (Pubitemid 40628411)
172. Nammi S., Sreemantula S., Roufogalis B. D., Protective effects of ethanolic extract of zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic and Clinical Pharmacology and Toxicology 2009 104 5 366 373 2-s2.0-64549145497 10.1111/j.1742-7843.2008.00362. x
173. Nammi S., Kim M. S., Gavande N. S., Li G. Q., Roufogalis B. D., Regulation of low-density lipoprotein receptor and 3-hydroxy-3- methylglutaryl coenzyme A reductase expression by zingiber officinale in the liver of high-fat diet-fed rats. Basic and Clinical Pharmacology and Toxicology 2010 106 5 389 395 2-s2.0-77951073882 10.1111/j.1742-7843.2009.00497.x
174. Li X.-H., McGrath K. C.-Y., Nammi S., Heather A. K., Roufogalis B. D., Attenuation of liver pro-inflammatory responses by zingiber officinale via inhibition of NF-kappa B activation in high-fat diet-fed rats. Basic and Clinical Pharmacology and Toxicology 2012 110 3 238 244 2-s2.0-84857363526 10.1111/j.1742-7843.2011.00791.x
175. Gao H., Guan T., Li C., Zuo G., Yamahara J., Wang J., Li Y., Treatment with ginger ameliorates fructose-induced fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway. Evidence-based Complementary and Alternative Medicine 2012 2012 12 2-s2.0-84870223869 10.1155/2012/570948 570948